Kanchan Bhatia | Biological Sciences | Best Researcher Award

Dr. Kanchan Bhatia | Biological Sciences | Best Researcher Award

 Clinical Assistant Professor at Arizona State University, United States.

🌍Dr. Kanchan Bhatia is a Clinical Assistant Professor at Arizona State University (ASU), specializing in toxicology, neurodegeneration, and cardiovascular research. With a strong academic background (Ph.D. from Jamia Hamdard) and extensive teaching and research experience in India, the USA, and Saudi Arabia, she has contributed significantly to scientific literature with 26 publications in reputed journals. Dr. Bhatia has received numerous awards for her exemplary teaching, research, and leadership, including the SUN Innovation Award (2021) and American Heart Association Postdoctoral Fellowship (2012). Her multidisciplinary expertise and dedication to student success are evident through her innovative teaching practices and impactful research.

Profile👤

Education 🎓

🎓Dr. Bhatia earned her Ph.D. in Toxicology from Jamia Hamdard, New Delhi, India, in 2008. She holds an M.S. in Biotechnology from the same institution and a B.S. in Microbiology from Delhi University. In 2022, she completed a Graduate Certificate in Clinical Trials Design and Management from the University of California, San Diego, enhancing her expertise in clinical research methodologies.🎓

Experience💼

🩺Since August 2020, Dr. Bhatia has served as a Clinical Assistant Professor at Arizona State University. Prior to this, she was an Instructor at the same institution from 2017 to 2020. Her experience includes roles as a Research Scientist at Texas Tech University Health Science Center and teaching and research positions at Jamia Hamdard and King Abdulaziz University. She also completed postdoctoral fellowships at Augusta University and UT Southwestern Medical Center.👨‍🔬🌍

Awards and Honors 🏆

Dr. Bhatia’s accolades include the 2024 SUN Award for exemplary service in supporting student success, and multiple SUN Awards in 2023 for leadership and social embeddedness. She received a Post-doctoral Fellowship from the American Heart Association in 2012 and has been honored with travel awards and research fellowships from prestigious organizations, reflecting her commitment to advancing scientific knowledge.

Research Interests 🔬

🔬Dr. Bhatia’s research centers on neurodegenerative disorders, with a particular emphasis on the role of the complement system in vascular dysfunction and cognitive impairment. She investigates the molecular mechanisms underlying conditions such as vascular cognitive impairment and stroke, aiming to develop therapeutic strategies that mitigate neuroinflammation and promote neuroprotection.🌿🧪

Conclusion 🔚 

Dr. Kanchan Bhatia’s multifaceted expertise, strong academic track record, and dedication to innovation and student success make her a deserving candidate for the Best Researcher Award. Addressing minor areas of improvement, such as increasing research funding and international collaborations, would further enhance her contributions to the academic and research community.

Publications Top Notes 📚

Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID

Authors: Bhatia, K., Kindelin, A., Nadeem, M., Ahmad, S., Ducruet, A.F.

Citations: 5

Year: 2022

Remote Ischemic Post-Conditioning Therapy is Protective in Mouse Model of Traumatic Optic Neuropathy

Authors: Nadeem, M., Kindelin, A., Mahady, L., Ducruet, A.F., Ahmad, S.

Citations: 8

Year: 2021

Complement C3a receptor-mediated vascular dysfunction: A complex interplay between aging and neurodegeneration

Authors: Bhatia, K., Ahmad, S., Kindelin, A., Ducruet, A.F.

Citations: 22

Year: 2021

C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke

Authors: Ahmad, S., Pandya, C., Kindelin, A., Hoda, M.N., Ducruet, A.F.

Citations: 11

Year: 2020

Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis

Authors: Akhter, N., Ahmad, S., Alzahrani, F.A., Alharbi, R.A., Sindi, A.A.-A.

Citations: 12

Year: 2020

Acetyl-11-keto-β-boswellic acid (AKBA) Attenuates Oxidative Stress, Inflammation, Complement Activation and Cell Death in Brain Endothelial Cells Following OGD/Reperfusion

Authors: Ahmad, S., Khan, S.A., Kindelin, A., Hoda, M.N., Ducruet, A.F.

Citations: 40

Year: 2019

The Role of Complement C3a Receptor in Stroke

Authors: Ahmad, S., Bhatia, K., Kindelin, A., Ducruet, A.F.

Citations: 17

Year: 2019

C3a receptor inhibition protects brain endothelial cells against oxygen-glucose deprivation/reperfusion

Authors: Ahmad, S., Kindelin, A., Khan, S.A., Bhatia, K., Ducruet, A.F.

Citations: 20

Year: 2019

Combined deficiency of Senataxin and DNA-PKcs causes DNA damage accumulation and neurodegeneration in spinal muscular atrophy

Authors: Kannan, A., Bhatia, K., Branzei, D., Gangwani, L.

Citations: 63

Year: 2018